Hoersholm, Denmark

Thomas Högberg

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: 7Tm Pharma A/s. Active years: 2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thomas Högberg. Retrieved from https://idiyas.com/inventor/thomas-högberg-e0e1285k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Högberg: Innovator in Medicinal Chemistry

Introduction

Thomas Högberg is a notable inventor based in Hørsholm, Denmark. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the CRTH2 receptor. His work is essential for advancing treatments for various allergic conditions.

Latest Patents

Högberg holds a patent for "CRTH2 receptor ligands for medicinal uses." This patent describes compounds that are useful for treating diseases responsive to modulation of CRTH2 receptor activity, such as asthma, rhinitis, allergic airway syndrome, and allergic rhinobronchitis. The compounds include specific structural features, such as a carboxyl group and various ring systems, which enhance their therapeutic potential.

Career Highlights

Currently, Thomas Högberg is associated with 7Tm Pharma A/S, where he continues to innovate in the field of pharmaceuticals. His expertise in medicinal chemistry has positioned him as a key player in developing new therapeutic agents.

Collaborations

Högberg collaborates with talented professionals in his field, including Marie Grimstrup and Trond Ulven. These partnerships enhance the research and development efforts at 7Tm Pharma A/S.

Conclusion

Thomas Högberg's contributions to medicinal chemistry and his innovative patent for CRTH2 receptor ligands underscore his importance in the field. His work continues to pave the way for new treatments for allergic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…